Cargando…
Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)
BACKGROUND: Atopic dermatitis (AD) is associated with reduced skin microbial diversity and overgrowth of Staphylococcus (S.) aureus. However, the importance of S. aureus colonisation in the complex pathogenesis remains unclear and studies on the effect of anti-staphylococcal therapy in non-infected...
Autores principales: | Totté, Joan, de Wit, Jill, Pardo, Luba, Schuren, Frank, van Doorn, Martijn, Pasmans, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580294/ https://www.ncbi.nlm.nih.gov/pubmed/28859690 http://dx.doi.org/10.1186/s13063-017-2118-x |
Ejemplares similares
-
Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with the Topical Endolysin Staphefekt SA.100: A Report of 3 Cases
por: Totté, Joan E.E., et al.
Publicado: (2017) -
The Skin and Nose Microbiome and Its Association with Filaggrin Gene Mutations in Pediatric Atopic Dermatitis
por: van Mierlo, Minke M.F., et al.
Publicado: (2022) -
Role of Staphylococcal Superantigen in Atopic Dermatitis: Influence on Keratinocytes
por: Kim, Kyu Han, et al.
Publicado: (2006) -
Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients
por: Moran, Mary C., et al.
Publicado: (2019) -
Staphylococcal Communities on Skin Are Associated with Atopic Dermatitis and Disease Severity
por: Edslev, Sofie Marie, et al.
Publicado: (2021)